| Jan 21, 2025 |
Jan 23, 2025 |
Phathom Pharmaceuticals, Inc.
|
CEO |
Sell |
42.5
|
-19,109
|
-4.98%
|
✗
|
$125.9K |
| Nov 11, 2024 |
Nov 13, 2024 |
Arcutis Biotherapeutics, Inc.
|
Director |
Sell |
22.5
|
-8,687
|
-46.14%
|
✗
|
$94.2K |
| Jul 15, 2024 |
Jul 17, 2024 |
Phathom Pharmaceuticals, Inc.
|
CEO |
Sell |
40.0
|
-33,848
|
-8.15%
|
✗
|
$396.7K |
| Mar 22, 2024 |
Mar 26, 2024 |
Phathom Pharmaceuticals, Inc.
|
CEO |
Sell |
22.5
|
-16,851
|
-3.91%
|
✗
|
$153.5K |
| Apr 6, 2023 |
Apr 7, 2023 |
Phathom Pharmaceuticals, Inc.
|
CEO |
Buy |
90.0
|
+12,919
|
7.27%
|
✗
|
$101K |
| Mar 1, 2023 |
Mar 3, 2023 |
Phathom Pharmaceuticals, Inc.
|
CEO |
Sell |
51.3
|
-1,436
|
-0.80%
|
✓
|
$12.3K |
| Jan 19, 2023 |
Jan 20, 2023 |
Phathom Pharmaceuticals, Inc.
|
CEO |
Sell |
91.3
|
+91,679
|
104.94%
|
✗
|
$47.7K |
| Nov 21, 2022 |
Nov 23, 2022 |
Phathom Pharmaceuticals, Inc.
|
CEO |
Sell |
46.3
|
-1,526
|
-1.74%
|
✗
|
$14.6K |
| May 13, 2022 |
May 16, 2022 |
Phathom Pharmaceuticals, Inc.
|
CEO |
Buy |
95.0
|
+20,500
|
45.74%
|
✗
|
$151.8K |
| Mar 22, 2021 |
Mar 23, 2021 |
Phathom Pharmaceuticals, Inc.
|
CEO |
Sell |
7.5
|
-11,513
|
-100.00%
|
✓
|
$498.8K |